Immunoglobulin G Replacement Therapy: Particularities of a Portuguese Cohort

Authors

  • Sofia Cosme Ferreira *Co-primeira autora. Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; Serviço de Imunoalergologia. Hospital Central do Funchal Dr. Nélio Mendonça. Serviço de Saúde da Região Autónoma da Madeira. Funchal. https://orcid.org/0000-0002-0920-1779
  • Josefina Vieira *Co-primeira autora. Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; Serviço de Imunoalergologia. Hospital Central do Funchal Dr. Nélio Mendonça. Serviço de Saúde da Região Autónoma da Madeira. Funchal. https://orcid.org/0000-0003-2591-774X
  • Maria Inês T. Silva *Co-primeira autora. Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; https://orcid.org/0000-0002-8041-1306
  • Sara P. Silva Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; Centro de Imunodeficiências Primárias. Centro Académico de Medicina de Lisboa. Lisboa; Instituto de Medicina Molecular João Lobo Antunes. Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-8838-5704
  • Joana Caiado Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; Serviço de Imunoalergologia. Hospital Central do Funchal Dr. Nélio Mendonça. Serviço de Saúde da Região Autónoma da Madeira. Funchal. https://orcid.org/0000-0003-3401-7903
  • Elisa Pedro Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa. https://orcid.org/0000-0002-1242-3524
  • Susana L. Silva Serviço de Imunoalergologia. Unidade Local de Saúde de Santa Maria. Lisboa; Instituto de Medicina Molecular João Lobo Antunes. Faculdade de Medicina. Universidade de Lisboa. Lisboa; Clínica Universitária de Imunoalergologia. Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0003-3943-1185

DOI:

https://doi.org/10.20344/amp.20677

Keywords:

Immunoglobulin G/therapeutic use

Abstract

N/a.

Downloads

Download data is not yet available.

References

Krivan G, Jolles S, Granados EL, Paolantonacci P, Ouaja R, Cissé OA, et al. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017;6:76-83.

Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15:71-81. DOI: https://doi.org/10.1016/j.autrev.2015.09.002

Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146-60. DOI: https://doi.org/10.1111/cei.12485

Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20:94-100. DOI: https://doi.org/10.1023/A:1006678312925

Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125:1354-60.e4. DOI: https://doi.org/10.1016/j.jaci.2010.02.040

Kittner JM, Grimbacher B, Wulff W, Jager B, Schmidt RE. Patients’ attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol. 2006;26:400-5. DOI: https://doi.org/10.1007/s10875-006-9031-5

Pulvirenti F, Cinetto F, Pecoraro A, Carrabba M, Crescenzi L, Neri R, et al. Health-related quality of life in patients with covid under different schedules of immunoglobulin administration: prospective multicenter study. J Clin Immunol. 2019;39:159-70. DOI: https://doi.org/10.1007/s10875-019-0592-5

Anterasian C, Duong R, Gruenemeier P, Ernst C, Kitsen J, Geng B. Quality of life differences for primary immunodeficiency patients on home SCIG versus IVIG. J Clin Immunol. 2019;39:814-22. DOI: https://doi.org/10.1007/s10875-019-00705-5

Overton PM, Shalet N, Somers F, Allen JA. Patient preferences for subcutaneous versus intravenous administration of treatment for chronic immune system disorders: a systematic review. Patient Prefer Adher. 2021;19:811-34. DOI: https://doi.org/10.2147/PPA.S303279

Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adher. 2014;2:621-9. DOI: https://doi.org/10.2147/PPA.S60771

Published

2024-03-04

How to Cite

1.
Cosme Ferreira S, Vieira J, T. Silva MI, P. Silva S, Caiado J, Pedro E, L. Silva S. Immunoglobulin G Replacement Therapy: Particularities of a Portuguese Cohort. Acta Med Port [Internet]. 2024 Mar. 4 [cited 2024 Apr. 23];37(4):239-42. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20677

Issue

Section

Perspective